Anticancer drug development:
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
San Diego
Academic Press
c2002
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | Here in a single source is a complete spectrum of ideas on the development of new anticancer drugs. Containing concise reviews of multidisciplinary fields of research, this book offers a wealth of ideas on current and future molecular targets for drug design, including signal transduction, the cell division cycle, and programmed cell death. Detailed descriptions of sources for new drugs and methods for testing and clinical trial design are also provided. KEY FEATURES: * One work that can be consulted for all aspects of anticancer drug development * Concise reviews of research fields, combined with practical scientific detail, written by internationally respected experts * A wealth of ideas on current and future molecular targets for drug design, including signal transduction, the cell division cycle, and programmed cell death * Detailed descriptions of the sources of new anticancer drugs, including combinatorial chemistry, phage display, and natural products * Discussion of how new drugs can be tested in preclinical systems, including the latest technology of robotic assay systems, cell culture, and experimental animal techniques * Hundreds of references that allow the reader to access relevant scientific and medical literature * Clear illustrations, some in color, that provide both understanding of the field and material for teaching Includes bibliographical references and index |
| Beschreibung: | 1 Online-Ressource (xiii, 397 p.) |
| ISBN: | 9780120726516 0120726513 9780080490441 0080490441 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV042305385 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 150129s2002 |||| o||u| ||||||eng d | ||
| 020 | |a 9780120726516 |9 978-0-12-072651-6 | ||
| 020 | |a 0120726513 |9 0-12-072651-3 | ||
| 020 | |a 9780080490441 |c electronic bk. |9 978-0-08-049044-1 | ||
| 020 | |a 0080490441 |c electronic bk. |9 0-08-049044-1 | ||
| 035 | |a (OCoLC)162129299 | ||
| 035 | |a (DE-599)BVBBV042305385 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 | ||
| 082 | 0 | |a 616.99/4061 |2 22 | |
| 245 | 1 | 0 | |a Anticancer drug development |c edited by Bruce C. Baguley, David J. Kerr |
| 264 | 1 | |a San Diego |b Academic Press |c c2002 | |
| 300 | |a 1 Online-Ressource (xiii, 397 p.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Here in a single source is a complete spectrum of ideas on the development of new anticancer drugs. Containing concise reviews of multidisciplinary fields of research, this book offers a wealth of ideas on current and future molecular targets for drug design, including signal transduction, the cell division cycle, and programmed cell death. Detailed descriptions of sources for new drugs and methods for testing and clinical trial design are also provided. KEY FEATURES: * One work that can be consulted for all aspects of anticancer drug development * Concise reviews of research fields, combined with practical scientific detail, written by internationally respected experts * A wealth of ideas on current and future molecular targets for drug design, including signal transduction, the cell division cycle, and programmed cell death * Detailed descriptions of the sources of new anticancer drugs, including combinatorial chemistry, phage display, and natural products * Discussion of how new drugs can be tested in preclinical systems, including the latest technology of robotic assay systems, cell culture, and experimental animal techniques * Hundreds of references that allow the reader to access relevant scientific and medical literature * Clear illustrations, some in color, that provide both understanding of the field and material for teaching | ||
| 500 | |a Includes bibliographical references and index | ||
| 650 | 4 | |a Antineoplastic Agents | |
| 650 | 4 | |a Drug Design | |
| 650 | 4 | |a Drug Evaluation, Preclinical | |
| 650 | 4 | |a Anticancéreux / Développement | |
| 650 | 4 | |a Cancer / Chimiothérapie | |
| 650 | 7 | |a MEDICAL / Oncology |2 bisacsh | |
| 650 | 7 | |a HEALTH & FITNESS / Diseases / Cancer |2 bisacsh | |
| 650 | 7 | |a Antineoplastic agents |2 fast | |
| 650 | 7 | |a Drug development |2 fast | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Antineoplastic agents | |
| 650 | 4 | |a Drug development | |
| 700 | 1 | |a Baguley, Bruce C. |e Sonstige |4 oth | |
| 700 | 1 | |a Kerr, David J. |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/book/9780120726516 |x Verlag |3 Volltext |
| 912 | |a ZDB-33-ESD |a ZDB-33-EBS | ||
| 940 | 1 | |q FAW_PDA_ESD | |
| 940 | 1 | |q FLA_PDA_ESD | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-027742377 | ||
Datensatz im Suchindex
| _version_ | 1804152888422825984 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV042305385 |
| collection | ZDB-33-ESD ZDB-33-EBS |
| ctrlnum | (OCoLC)162129299 (DE-599)BVBBV042305385 |
| dewey-full | 616.99/4061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/4061 |
| dewey-search | 616.99/4061 |
| dewey-sort | 3616.99 44061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03103nmm a2200529zc 4500</leader><controlfield tag="001">BV042305385</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">150129s2002 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780120726516</subfield><subfield code="9">978-0-12-072651-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0120726513</subfield><subfield code="9">0-12-072651-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780080490441</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-08-049044-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0080490441</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-08-049044-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)162129299</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042305385</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/4061</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Anticancer drug development</subfield><subfield code="c">edited by Bruce C. Baguley, David J. Kerr</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">San Diego</subfield><subfield code="b">Academic Press</subfield><subfield code="c">c2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xiii, 397 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Here in a single source is a complete spectrum of ideas on the development of new anticancer drugs. Containing concise reviews of multidisciplinary fields of research, this book offers a wealth of ideas on current and future molecular targets for drug design, including signal transduction, the cell division cycle, and programmed cell death. Detailed descriptions of sources for new drugs and methods for testing and clinical trial design are also provided. KEY FEATURES: * One work that can be consulted for all aspects of anticancer drug development * Concise reviews of research fields, combined with practical scientific detail, written by internationally respected experts * A wealth of ideas on current and future molecular targets for drug design, including signal transduction, the cell division cycle, and programmed cell death * Detailed descriptions of the sources of new anticancer drugs, including combinatorial chemistry, phage display, and natural products * Discussion of how new drugs can be tested in preclinical systems, including the latest technology of robotic assay systems, cell culture, and experimental animal techniques * Hundreds of references that allow the reader to access relevant scientific and medical literature * Clear illustrations, some in color, that provide both understanding of the field and material for teaching</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Design</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Evaluation, Preclinical</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anticancéreux / Développement</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer / Chimiothérapie</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Oncology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS / Diseases / Cancer</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antineoplastic agents</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug development</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Baguley, Bruce C.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kerr, David J.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/book/9780120726516</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-33-ESD</subfield><subfield code="a">ZDB-33-EBS</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">FAW_PDA_ESD</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">FLA_PDA_ESD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-027742377</subfield></datafield></record></collection> |
| id | DE-604.BV042305385 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T01:17:52Z |
| institution | BVB |
| isbn | 9780120726516 0120726513 9780080490441 0080490441 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-027742377 |
| oclc_num | 162129299 |
| open_access_boolean | |
| owner | DE-1046 |
| owner_facet | DE-1046 |
| physical | 1 Online-Ressource (xiii, 397 p.) |
| psigel | ZDB-33-ESD ZDB-33-EBS FAW_PDA_ESD FLA_PDA_ESD |
| publishDate | 2002 |
| publishDateSearch | 2002 |
| publishDateSort | 2002 |
| publisher | Academic Press |
| record_format | marc |
| spelling | Anticancer drug development edited by Bruce C. Baguley, David J. Kerr San Diego Academic Press c2002 1 Online-Ressource (xiii, 397 p.) txt rdacontent c rdamedia cr rdacarrier Here in a single source is a complete spectrum of ideas on the development of new anticancer drugs. Containing concise reviews of multidisciplinary fields of research, this book offers a wealth of ideas on current and future molecular targets for drug design, including signal transduction, the cell division cycle, and programmed cell death. Detailed descriptions of sources for new drugs and methods for testing and clinical trial design are also provided. KEY FEATURES: * One work that can be consulted for all aspects of anticancer drug development * Concise reviews of research fields, combined with practical scientific detail, written by internationally respected experts * A wealth of ideas on current and future molecular targets for drug design, including signal transduction, the cell division cycle, and programmed cell death * Detailed descriptions of the sources of new anticancer drugs, including combinatorial chemistry, phage display, and natural products * Discussion of how new drugs can be tested in preclinical systems, including the latest technology of robotic assay systems, cell culture, and experimental animal techniques * Hundreds of references that allow the reader to access relevant scientific and medical literature * Clear illustrations, some in color, that provide both understanding of the field and material for teaching Includes bibliographical references and index Antineoplastic Agents Drug Design Drug Evaluation, Preclinical Anticancéreux / Développement Cancer / Chimiothérapie MEDICAL / Oncology bisacsh HEALTH & FITNESS / Diseases / Cancer bisacsh Antineoplastic agents fast Drug development fast Medizin Antineoplastic agents Drug development Baguley, Bruce C. Sonstige oth Kerr, David J. Sonstige oth http://www.sciencedirect.com/science/book/9780120726516 Verlag Volltext |
| spellingShingle | Anticancer drug development Antineoplastic Agents Drug Design Drug Evaluation, Preclinical Anticancéreux / Développement Cancer / Chimiothérapie MEDICAL / Oncology bisacsh HEALTH & FITNESS / Diseases / Cancer bisacsh Antineoplastic agents fast Drug development fast Medizin Antineoplastic agents Drug development |
| title | Anticancer drug development |
| title_auth | Anticancer drug development |
| title_exact_search | Anticancer drug development |
| title_full | Anticancer drug development edited by Bruce C. Baguley, David J. Kerr |
| title_fullStr | Anticancer drug development edited by Bruce C. Baguley, David J. Kerr |
| title_full_unstemmed | Anticancer drug development edited by Bruce C. Baguley, David J. Kerr |
| title_short | Anticancer drug development |
| title_sort | anticancer drug development |
| topic | Antineoplastic Agents Drug Design Drug Evaluation, Preclinical Anticancéreux / Développement Cancer / Chimiothérapie MEDICAL / Oncology bisacsh HEALTH & FITNESS / Diseases / Cancer bisacsh Antineoplastic agents fast Drug development fast Medizin Antineoplastic agents Drug development |
| topic_facet | Antineoplastic Agents Drug Design Drug Evaluation, Preclinical Anticancéreux / Développement Cancer / Chimiothérapie MEDICAL / Oncology HEALTH & FITNESS / Diseases / Cancer Antineoplastic agents Drug development Medizin |
| url | http://www.sciencedirect.com/science/book/9780120726516 |
| work_keys_str_mv | AT baguleybrucec anticancerdrugdevelopment AT kerrdavidj anticancerdrugdevelopment |